ONCONASE Plus Doxorubicin Versus Doxorubicin For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 02 Aug 2009
At a glance
- Drugs Doxorubicin; Ranpirnase
- Indications Mesothelioma
- Focus Registrational; Therapeutic Use
- 02 Aug 2009 Results presented at IASLC 2009.
- 02 Jun 2009 Results were presented at ASCO 2009.
- 28 May 2008 Primary endpoint not met; preliminary results reported in an Alfacell media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History